Peregrine Capital Management LLC Acquires 2,168 Shares of Prestige Consumer Healthcare Inc (NYSE:PBH)

Peregrine Capital Management LLC lifted its holdings in shares of Prestige Consumer Healthcare Inc (NYSE:PBH) by 1.5% in the 2nd quarter, HoldingsChannel reports. The fund owned 151,513 shares of the company’s stock after purchasing an additional 2,168 shares during the period. Peregrine Capital Management LLC’s holdings in Prestige Consumer Healthcare were worth $5,691,000 as of its most recent SEC filing.

Several other large investors have also bought and sold shares of PBH. Norges Bank bought a new stake in shares of Prestige Consumer Healthcare during the fourth quarter worth about $25,909,000. Macquarie Group Ltd. increased its position in shares of Prestige Consumer Healthcare by 14.4% during the fourth quarter. Macquarie Group Ltd. now owns 2,001,580 shares of the company’s stock worth $81,065,000 after acquiring an additional 251,580 shares in the last quarter. Nuveen Asset Management LLC increased its position in shares of Prestige Consumer Healthcare by 18.9% during the first quarter. Nuveen Asset Management LLC now owns 1,346,190 shares of the company’s stock worth $49,379,000 after acquiring an additional 213,939 shares in the last quarter. AQR Capital Management LLC increased its position in shares of Prestige Consumer Healthcare by 1,051.3% during the first quarter. AQR Capital Management LLC now owns 137,265 shares of the company’s stock worth $5,007,000 after acquiring an additional 125,342 shares in the last quarter. Finally, Grantham Mayo Van Otterloo & Co. LLC increased its position in shares of Prestige Consumer Healthcare by 40.5% during the first quarter. Grantham Mayo Van Otterloo & Co. LLC now owns 434,500 shares of the company’s stock worth $15,937,000 after acquiring an additional 125,200 shares in the last quarter.

A number of brokerages have issued reports on PBH. BMO Capital Markets upped their price objective on shares of Prestige Consumer Healthcare from $91.00 to $95.00 and gave the stock a “market perform” rating in a research report on Friday, July 24th. ValuEngine downgraded shares of Prestige Consumer Healthcare from a “sell” rating to a “strong sell” rating in a research report on Thursday, July 2nd. Jefferies Financial Group downgraded shares of Prestige Consumer Healthcare from a “buy” rating to a “hold” rating in a research report on Tuesday, April 14th. CIBC upped their price objective on shares of Prestige Consumer Healthcare from $86.00 to $88.00 and gave the stock a “neutral” rating in a research report on Tuesday, May 12th. Finally, TD Securities upped their price objective on shares of Prestige Consumer Healthcare from $90.00 to $97.00 and gave the stock a “hold” rating in a research report on Friday, July 24th. One analyst has rated the stock with a sell rating, six have issued a hold rating and two have assigned a buy rating to the company’s stock. Prestige Consumer Healthcare has a consensus rating of “Hold” and an average target price of $65.43.

Prestige Consumer Healthcare stock opened at $37.19 on Friday. Prestige Consumer Healthcare Inc has a twelve month low of $27.40 and a twelve month high of $46.12. The firm has a 50 day moving average price of $38.20 and a 200-day moving average price of $39.22. The company has a market capitalization of $1.87 billion, a P/E ratio of 13.38, a P/E/G ratio of 3.11 and a beta of 0.80. The company has a quick ratio of 1.67, a current ratio of 2.44 and a debt-to-equity ratio of 1.50.

Prestige Consumer Healthcare (NYSE:PBH) last released its earnings results on Thursday, May 7th. The company reported $0.82 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.74 by $0.08. Prestige Consumer Healthcare had a net margin of 14.77% and a return on equity of 13.33%. The firm had revenue of $251.20 million during the quarter, compared to the consensus estimate of $239.65 million. During the same period in the prior year, the firm earned $0.72 EPS. The company’s revenue was up 4.2% compared to the same quarter last year. Equities analysts expect that Prestige Consumer Healthcare Inc will post 2.99 EPS for the current fiscal year.

In other news, CEO Ronald M. Lombardi sold 29,593 shares of the stock in a transaction that occurred on Tuesday, May 12th. The shares were sold at an average price of $40.00, for a total transaction of $1,183,720.00. Following the completion of the transaction, the chief executive officer now directly owns 154,630 shares of the company’s stock, valued at approximately $6,185,200. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 1.20% of the stock is owned by corporate insiders.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) healthcare and household cleaning products in North America, Australia, and internationally. It operates in three segments: North American OTC Healthcare, International OTC Healthcare, and Household Cleaning.

Featured Article: What is a Futures Contract?

Want to see what other hedge funds are holding PBH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Prestige Consumer Healthcare Inc (NYSE:PBH).

Institutional Ownership by Quarter for Prestige Consumer Healthcare (NYSE:PBH)

Receive News & Ratings for Prestige Consumer Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.